Cell lysates were subjected to immunoblotting with anti-TCL1A antibodies
Cell lysates were subjected to immunoblotting with anti-TCL1A antibodies. by obstructing amplification of anti-tumor immunity. Previously, we found that immune selection by immunotherapy drives the development...